HomeCompareNOBL vs ISRG

NOBL vs ISRG: Dividend Comparison 2026

NOBL yields 2.17% · ISRG yields 0.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOBL wins by $2.6K in total portfolio value
10 years
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →
ISRG
ISRG
● Live price
0.44%
Share price
$452.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$45.46
Full ISRG calculator →

Portfolio growth — NOBL vs ISRG

📍 NOBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNOBLISRG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NOBL + ISRG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NOBL pays
ISRG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
ISRG
Annual income on $10K today (after 15% tax)
$37.55/yr
After 10yr DRIP, annual income (after tax)
$38.64/yr
At 15% tax rate, NOBL beats the other by $173.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NOBL + ISRG for your $10,000?

NOBL: 50%ISRG: 50%
100% ISRG50/50100% NOBL
Portfolio after 10yr
$21.6K
Annual income
$147.62/yr
Blended yield
0.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ISRG right now

NOBL
No analyst data
ISRG
Analyst Ratings
37
Buy
12
Hold
5
Sell
Consensus: Buy
Price Target
$638.75
+41.1% upside vs current
Range: $550.00 — $750.00
Altman Z
37.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NOBL buys
0
ISRG buys
0
No recent congressional trades found for NOBL or ISRG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNOBLISRG
Forward yield2.17%0.44%
Annual dividend / share$2.27$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$22.9K$20.3K
Annual income after 10y$249.78$45.46
Total dividends collected$2.3K$449.00
Payment frequencyquarterlyquarterly
SectorETFStock

Year-by-year: NOBL vs ISRG ($10,000, DRIP)

YearNOBL PortfolioNOBL Income/yrISRG PortfolioISRG Income/yrGap
1← crossover$10,917$217.08$10,744$44.17+$173.00NOBL
2$11,903$221.48$11,541$44.35+$362.00NOBL
3$12,962$225.68$12,393$44.53+$569.00NOBL
4$14,099$229.68$13,305$44.69+$794.00NOBL
5$15,319$233.49$14,281$44.84+$1.0KNOBL
6$16,628$237.10$15,326$44.98+$1.3KNOBL
7$18,033$240.53$16,444$45.11+$1.6KNOBL
8$19,539$243.78$17,640$45.23+$1.9KNOBL
9$21,154$246.86$18,920$45.35+$2.2KNOBL
10$22,884$249.78$20,290$45.46+$2.6KNOBL

NOBL vs ISRG: Complete Analysis 2026

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

ISRGStock

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Full ISRG Calculator →
📬

Get this NOBL vs ISRG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NOBL vs SCHDNOBL vs JEPINOBL vs ONOBL vs KONOBL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.